Bacteria strain and bacteriocin produced therefrom
AssigneeUniversite Laval
InventorsIsmail Fliss, Michel Desbiens, Christophe Lacroix, Imane Tahiri, Régis-Olivier Benech, Ehab Kheadr
Life of this patent
Estimating the term…
Abstract
The present invention concerns an isolated bacteriocin, Divergicin M35, derived form Carnobacterium divergens M35. It also concerns a composition comprising an effective amount of Divergicin M35 and the use of that bacteriocin to kill or limit the proliferation of a microorganism.
Claims6
A purified bacteriocin that comprises the amino acid sequence of SEQ. ID. NO:
- 1, wherein said bacteriocin presents an antimicrobial activity towards a bacteria of the Listeria genus.
A composition for killing a bacteria of the Listeria genus or limiting its proliferation that comprises (i) an effective amount of a purified bacteriocin and (ii) a carrier, wherein said purified bacteriocin comprises the amino acid sequence of SEQ. ID. NO:
- 1.
A method for killing a bacteria of the Listeria genus or limiting its proliferation by adding an affective amount of a purified bacteriocin that comprises the amino acid sequence of SEQ ID NO:
- 1 to said bacteria of the Listeria genus.
Dependencies are inferred from the claim text.